MODERN STATE OF THE PROBLEM HIV/AIDS IN CHILDREN

Nabieva D.D.

doi:10.5281/zenodo.11357302

MODERN STATE OF THE PROBLEM HIV/AIDS IN CHILDREN

27.05.2024 International Scientific Journal "Science and Innovation". Series D. Volume 3 Issue 5

Nabieva D.D.

Abstract. Every day, the number of HIV-infected children around the world is increasing, mainly through vertical transmission in utero, during childbirth or in the postnatal period through breastfeeding. Also, one of the most important reasons is the lack of antiretroviral therapy in HIV-infected pregnant women, which can prevent transmission of the infection to the child.

Keywords: HIV, AIDS, HIV/AIDS, human immunodeficiency virus, acquired immunodeficiency syndrome

References:

1. Centers for Disease Control (CDC). Pneumocystis pneumonia - Los Angeles. MMWR Morb Mortal Wkly Rep. 1981; 30 :250–2. 2. De Kock K.M., Jaffe H.W., Curran J.W. Reflections on the 30th anniversary of the fight against AIDS. Emergency infection Dis. 2011; 17:1044–8. 10.3201/eid/1706.100184 3. Centers for Disease Control and Prevention. Compendium of evidence-based interventions and best practices for HIV prevention [cited April 18, 2021]. https://www.cdc.gov/hiv/research/interventionresearch/compendium/index.html 4. Barré-Sinoussi F, Chermann J-C, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220:868–71. 10.1126/science.6189183 5. Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984;224:497–500. 10.1126/science.6200935 6. Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonosis: scientific and public health implications. Science. 2000;287:607–14. 10.1126/science.287.5453.607 7. France D. How to survive a plague: the inside story of how citizens and science tamed AIDS. New York: Alfred Knopf; 2016. 8. Merson M, Inrig S. The AIDS pandemic. Searching for a global response. 2018. Cham (Switzerland); Springer International Publishing; 2018. p. 25–113. 9. Joint United Nations Program on HIV/AIDS. UNAIDS data 2020. [cited 2021 Apr 18]. 10. Centers for Disease Control and Prevention. HIV surveillance report, 2018. (Preliminary); vol. 30 [cited 2021 Mar 14]. 11. Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J, et al.; Indiana HIV Outbreak Investigation Team. HIV infection linked to injection use of oxymorphone in Indiana, 2014–2015. N Engl J Med. 2016;375:229–39. 10.1056/NEJMoa1515195 12. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al.; CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–74. 10.1126/science.1193748 13. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al.; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–99. 10.1056/NEJMoa1011205 14. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al.; Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399–410. 10.1056/NEJMoa1108524 15. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomized trial. Lancet. 2016;387:53–60. 10.1016/S0140-6736(15)00056-2